EC Number   |
Title |
Organism |
|---|
   3.4.22.16 | 2,5-Diaryloxadiazoles and their precursors as novel inhibitors of cathepsins B, H and L |
Capra hircus |
| 3.4.22.16 | A comparative account of sar studies of semicarbazones and thiosemicarbazones on cathepsins H and L |
Capra hircus |
| 3.4.22.16 | A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis |
Rattus norvegicus |
| 3.4.22.16 | A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis |
Homo sapiens |
| 3.4.22.16 | A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis |
Mus musculus |
| 3.4.22.16 | A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis |
Mus musculus C57BL/6J |
| 3.4.22.16 | Chalcones, semicarbazones and pyrazolines as inhibitors of cathepsins B, H and L |
Capra hircus |
| 3.4.22.16 | Crystal structures of human procathepsin H |
Homo sapiens |
| 3.4.22.16 | Inhibitory potential of some chalcones on cathepsins B, H and L |
Capra hircus |
| 3.4.22.16 | 2,3-Dihydroquinazolin-4(1H)-one derivatives as potential non-peptidyl inhibitors of cathepsins B and H |
Capra hircus |
